Canada markets closed

Myomo, Inc. (MYO)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
3.4300+0.0100 (+0.29%)
At close: 04:00PM EDT
3.3700 -0.06 (-1.75%)
After hours: 06:03PM EDT

Myomo, Inc.

137 Portland Street
4th Floor
Boston, MA 02114
United States
617-996-9058
https://myomo.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees101

Key Executives

NameTitlePayExercisedYear Born
Mr. Paul R. GudonisChairman, President & CEO358.79kN/A1955
Mr. David A. HenryChief Financial Officer273.1kN/A1961
Dr. Harry Kovelman M.D.Chief Medical Officer277.58kN/A1959
Colin AndersonGlobal Director of OperationsN/AN/AN/A
Mr. Joseph ChicoskieDirector of MarketingN/AN/AN/A
Ms. Galina ShtivelmanSenior Director of Human ResourcesN/AN/AN/A
Mr. Micah J. MitchellChief Commercial Officer317.39kN/A1976
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Corporate Governance

Myomo, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.